FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of Big news for mens health. The FDA is officially advancing 12 high demand peptides including BPC 157, GHK Cu, and TB500 toward the next phase this July clearing the path for broader access and renewed Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy FDA considers adding a dozen peptides to its bulk drug compounding list RAPS